Total raised
$18.8M
Last: Undisclosed 2021-08
Stage
Series B
Founded
2015
Headcount
20
HQ
Ra'anana
Sector
Health Tech & Life Sciences
About
CorNeat Vision is a medical device company developing and marketing novel, permanent and tissue-integrating implants. Our platform material technology, CorNeat EverMatrix™, overcomes the main issue with implants and implantables – the foreign body response they trigger.
The EverMatrix™ seamlessly and permanently embeds with live tissue without triggering an inflammatory response. Its durability and flexibility, coupled with its bio-integration capabilities, mark a new era of implants.
The EverMatrix™ is set to displace harvested and processed human and animal tissues, including scaffolds and extra cellular matrices, used in a variety of surgical procedures across diversified fields of medicine.
Funding history · 4 rounds · $18.8M total
2021-08
Undisclosed
$4.0M
2020-05
Series B
$3.4M
2018-12
Series A
$7.2M
2017-11
Seed
$1.4M
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyBiomaterials & Tissue Engineering
Technologies
Materials & SubstancesImplants
Target customers
Healthcare & Life SciencesHealthcareProviders
Business model
B2B
Highlights
1 PatentsVerified
Tags
healthcaremedical-devicesvisually-impairedeye-diseases